202 related articles for article (PubMed ID: 17852951)
1. The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza.
McCullers JA; Iverson AR; McKeon R; Murray PJ
Scand J Infect Dis; 2008; 40(1):11-7. PubMed ID: 17852951
[TBL] [Abstract][Full Text] [Related]
2. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor.
McCullers JA; Rehg JE
J Infect Dis; 2002 Aug; 186(3):341-50. PubMed ID: 12134230
[TBL] [Abstract][Full Text] [Related]
3. Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice.
Rijneveld AW; Weijer S; Florquin S; Speelman P; Shimizu T; Ishii S; van der Poll T
J Infect Dis; 2004 Feb; 189(4):711-6. PubMed ID: 14767826
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia.
van der Sluijs KF; van Elden LJ; Nijhuis M; Schuurman R; Florquin S; Shimizu T; Ishii S; Jansen HM; Lutter R; van der Poll T
Am J Physiol Lung Cell Mol Physiol; 2006 Jan; 290(1):L194-9. PubMed ID: 16100290
[TBL] [Abstract][Full Text] [Related]
5. Signalling or binding: the role of the platelet-activating factor receptor in invasive pneumococcal disease.
Iovino F; Brouwer MC; van de Beek D; Molema G; Bijlsma JJ
Cell Microbiol; 2013 Jun; 15(6):870-81. PubMed ID: 23444839
[TBL] [Abstract][Full Text] [Related]
6. Expression and DNA microarray analysis of a platelet activating factor-related molecule in severe pneumonia in mice due to influenza virus and bacterial co-infection.
Seki M; Kosai K; Hara A; Imamura Y; Nakamura S; Kurihara S; Izumikawa K; Kakeya H; Yamamoto Y; Yanagihara K; Miyazaki Y; Mukae H; Tashiro T; Kohno S
Jpn J Infect Dis; 2009 Jan; 62(1):6-10. PubMed ID: 19168951
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice.
Garcia CC; Russo RC; Guabiraba R; Fagundes CT; Polidoro RB; Tavares LP; Salgado AP; Cassali GD; Sousa LP; Machado AV; Teixeira MM
PLoS Pathog; 2010 Nov; 6(11):e1001171. PubMed ID: 21079759
[TBL] [Abstract][Full Text] [Related]
8. Prevotella intermedia induces severe bacteremic pneumococcal pneumonia in mice with upregulated platelet-activating factor receptor expression.
Nagaoka K; Yanagihara K; Morinaga Y; Nakamura S; Harada T; Hasegawa H; Izumikawa K; Ishimatsu Y; Kakeya H; Nishimura M; Kohno S
Infect Immun; 2014 Feb; 82(2):587-93. PubMed ID: 24478074
[TBL] [Abstract][Full Text] [Related]
9. Exposure to welding fumes and lower airway infection with Streptococcus pneumoniae.
Suri R; Periselneris J; Lanone S; Zeidler-Erdely PC; Melton G; Palmer KT; Andujar P; Antonini JM; Cohignac V; Erdely A; Jose RJ; Mudway I; Brown J; Grigg J
J Allergy Clin Immunol; 2016 Feb; 137(2):527-534.e7. PubMed ID: 26277596
[TBL] [Abstract][Full Text] [Related]
10. GP96 Drives Exacerbation of Secondary Bacterial Pneumonia following Influenza A Virus Infection.
Sumitomo T; Nakata M; Nagase S; Takahara Y; Honda-Ogawa M; Mori Y; Akamatsu Y; Yamaguchi M; Okamoto S; Kawabata S
mBio; 2021 Jun; 12(3):e0326920. PubMed ID: 34061598
[TBL] [Abstract][Full Text] [Related]
11. An antagonist of the platelet-activating factor receptor inhibits adherence of both nontypeable Haemophilus influenzae and Streptococcus pneumoniae to cultured human bronchial epithelial cells exposed to cigarette smoke.
Shukla SD; Fairbairn RL; Gell DA; Latham RD; Sohal SS; Walters EH; O'Toole RF
Int J Chron Obstruct Pulmon Dis; 2016; 11():1647-55. PubMed ID: 27524890
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
[TBL] [Abstract][Full Text] [Related]
13. Unveiling the burden of influenza-associated pneumococcal pneumonia.
Grijalva CG; Griffin MR
J Infect Dis; 2012 Feb; 205(3):355-7. PubMed ID: 22158562
[No Abstract] [Full Text] [Related]
14. beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae.
Radin JN; Orihuela CJ; Murti G; Guglielmo C; Murray PJ; Tuomanen EI
Infect Immun; 2005 Dec; 73(12):7827-35. PubMed ID: 16299272
[TBL] [Abstract][Full Text] [Related]
15. Prevention of influenza virus induced bacterial superinfection by standardized Echinacea purpurea, via regulation of surface receptor expression in human bronchial epithelial cells.
Vimalanathan S; Schoop R; Suter A; Hudson J
Virus Res; 2017 Apr; 233():51-59. PubMed ID: 28279802
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infection.
Fukuda Y; Furuya Y; Nozaki Y; Takahata M; Nomura N; Mitsuyama J
Diagn Microbiol Infect Dis; 2014 Feb; 78(2):168-71. PubMed ID: 24321356
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor receptor contributes to host defense against Pseudomonas aeruginosa pneumonia but is not essential for the accompanying inflammatory and procoagulant response.
van Zoelen MA; Florquin S; Meijers JC; de Beer R; de Vos AF; de Boer OJ; van der Poll T
J Immunol; 2008 Mar; 180(5):3357-65. PubMed ID: 18292561
[TBL] [Abstract][Full Text] [Related]
18. Insights into the interaction between influenza virus and pneumococcus.
McCullers JA
Clin Microbiol Rev; 2006 Jul; 19(3):571-82. PubMed ID: 16847087
[TBL] [Abstract][Full Text] [Related]
19. Hypersusceptibility to invasive pneumococcal infection in experimental sickle cell disease involves platelet-activating factor receptor.
Miller ML; Gao G; Pestina T; Persons D; Tuomanen E
J Infect Dis; 2007 Feb; 195(4):581-4. PubMed ID: 17230418
[TBL] [Abstract][Full Text] [Related]
20. Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.
Wu Y; Tu W; Lam KT; Chow KH; Ho PL; Guan Y; Peiris JS; Lau YL
J Virol; 2015 Feb; 89(4):2013-23. PubMed ID: 25428873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
